维普中文期刊产品整合服务
48篇 您的检索式:作者名="Reiman R"
    题名 作者 年代 出处 被引量
1Exposure to endotoxinsand microbes in the treatment of waste water and in the industrial debarking of wood 显示文摘] Sarantila R Reiman M Kangas J 2001BuUetin of Environmental Contamination and Toxicology2001,67,2:1
2Central nervous system targeted exp ression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis显示文摘Davoust N Nataf S Reiman R 1999Immunol1999,163,12:1
3Cross-validation study of class Ⅲ beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials显示文摘Reiman T Lai R Veillard AS 2012Ann Oncol2012,23,1:1
4Class Ⅲ beta-tubulin expression and benefit form adjuvant cisplatin/vinorebine chemotherapy in operable non-small cell lung cancer:analysis of NCIC JBR 10显示文摘Seve P Lai R Reiman T 2007Clin Cancer Res2007,13,3:1
5IgG antbodies, chronic bronchitis, and pulmonary function values in famer' s lung pa- tients and matched controls显示文摘R Erkinjuntti-Pekkanen M Reiman JIKokkarinen 1999Allergy1999,54,:1
6Primary retro- peritoneal neoplasm CT findings in 90 cases with clini- cal and pathologic correlation显示文摘Lane R H Stephens D H Reiman H M 1989AJR Am J Roentgen- o11989,152,1:1
7Central nervous sytem-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis 显示文摘Davoust N Nataf S Reiman R 1999Immunol1999,,12:1
8Neural correlates of levels of emotional awareness:Evidence of an interaction between emotion and attention in the anterior cingulate cortex显示文摘 Reiman E M Axelrod B 1998Journal of Cognitive Neuroscience1998,10,4:1
9Cross-validation study of class HI beta tubulin as a predictive marker for benefit from adiuvant chemotherapy in resected non-small cell lung cancer: analysis of four randomized trials显示文摘REIMAN T LAI R VEILLARD A S 2012Ann Oncol2012,23,1:1
10Class Ⅲ beta tubulin expression and benefit from adjuvant cisplatin/ vinorelbine chemotherapy in operable non-small-cell lung cancer: Analysis of the National Cancer Institute of Canada Clinical Trials Group ( NCIC CTG ) study JBR10显示文摘Reiman T Lai R Ding K 2006Proc Am Soc Clin Oncol2006,25,:1
11Class Ⅲ beta-tabulin is a marker of paclitaxel resistance in carcinomas of unknown primary site显示文摘Seve P Reiman T Laj R 2007Cancer Chemother Pharmacol2007,60,1:1
12Considerations in the design of clinical trials for cognitive aging 显示文摘Reiman EM Brinton RD Katz R 2012J Gerontol A Bioi Sci Med Sci2012,67,7:1
13Central nervous sytem - targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis显示文摘Davoust N Nataf S Reiman R 1999J Immunol1999,163,:1
14Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E显示文摘 Caselli R J Yun LS 1996N Engl J Med1996,334,12:1
15Heavy traffic analysis of the dynamic stochastic inventory-routing problem显示文摘REIMAN M I RUBIO R WEIN L M 1999Transportation Science1999,33,4:1
16Cross-validation study of classⅢ beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials显示文摘Reiman T Lai R Veillard AS 2012Ann Oncol2012,23,1:1
17Primary retroperitoneal neoplasms:CT findings in 90 cases with clinical and pathologic correlation显示文摘Lane R Stephens DH Reiman HM 1989Am J Roentgenol1989,152,:1
18Class Ⅲ beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site显示文摘Seve P Reiman T Lai R 2007Cancer Chemother Pharmacol2007,60,1:1
19Class Ⅲ beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site显示文摘Sève P Reiman T Lai R 2007Cancer Chemother Pharmacol2007,60,:1
20Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis 显示文摘Davoust N Nataf S Reiman R 1999J Immunol1999,163,12:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费